Cargando…
Reduction of the HIV-1 reservoir in resting CD4(+ )T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study
BACKGROUND: The latency of HIV-1 in resting CD4(+ )T-lymphocytes constitutes a major obstacle for the eradication of virus in patients on antiretroviral therapy (ART). As yet, no approach to reduce this viral reservoir has proven effective. METHODS: Nine subjects on effective ART were included in th...
Autores principales: | Lindkvist, Annica, Edén, Arvid, Norström, Melissa M, Gonzalez, Veronica D, Nilsson, Staffan, Svennerholm, Bo, Karlsson, Annika C, Sandberg, Johan K, Sönnerborg, Anders, Gisslén, Magnus |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713257/ https://www.ncbi.nlm.nih.gov/pubmed/19570221 http://dx.doi.org/10.1186/1742-6405-6-15 |
Ejemplares similares
-
Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV
por: Mellberg, Tomas, et al.
Publicado: (2011) -
Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection
por: Edén, Arvid, et al.
Publicado: (2023) -
Higher plasma drug levels in elderly people living with HIV treated with darunavir
por: Tyrberg, Erika, et al.
Publicado: (2021) -
Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
por: Sörstedt, Erik, et al.
Publicado: (2016) -
Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up
por: Kanberg, Nelly, et al.
Publicado: (2021)